Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?

摘要： De novo lipogenesis(DNL) plays an important role in the pathogenesis of hepatic steatosis and also appears to be implicated in hepatic inflammation and fibrosis. Accordingly, the inhibition ... ... （共5頁(yè)）